Biotech Firms Spot Opportunity As Baby-Boomer Generation Ages

Generation Ages Author: Karen Young Kreeger Date: February 19, 1996 As the baby-boomer generation gets older, biotech companies are stepping up their research efforts with the goal of capitalizing on the huge potential market for anti-aging products. The number of drugs and therapies in development for diseases of the elderly increased from 125 in 1993 to 132 in July 1995. The number of companies developing those remedies climbed from 60 to 71 in the same time frame, according to New Medicines

Karen Young Kreeger
Feb 18, 1996

Generation Ages Author: Karen Young Kreeger
Date: February 19, 1996

As the baby-boomer generation gets older, biotech companies are stepping up their research efforts with the goal of capitalizing on the huge potential market for anti-aging products. The number of drugs and therapies in development for diseases of the elderly increased from 125 in 1993 to 132 in July 1995. The number of companies developing those remedies climbed from 60 to 71 in the same time frame, according to New Medicines in Development for Older Americans (Pharmaceutical Research and Manufacturers of America [PhRMA], Washington, D.C., 1995).

Daniel Perry No Voodoo Science: Understanding the aging process is no longer the stuff of science fiction, says Daniel Perry. And last fall, experts in a number of fields assembled by Batelle Memorial Institute, a consulting firm in Columbus, Ohio, listed anti-aging products and devices seventh on a top-10 list of technologies most likely to bring...